{
  "nbformat": 4,
  "nbformat_minor": 0,
  "metadata": {
    "colab": {
      "provenance": []
    },
    "kernelspec": {
      "name": "python3",
      "display_name": "Python 3"
    },
    "language_info": {
      "name": "python"
    }
  },
  "cells": [
    {
      "cell_type": "code",
      "source": [
        "!pip install roman"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "_xUOgP9UJOdz",
        "outputId": "ab2c9324-5199-42fd-fb27-1870bebc2988"
      },
      "execution_count": 1,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "Looking in indexes: https://pypi.org/simple, https://us-python.pkg.dev/colab-wheels/public/simple/\n",
            "Collecting roman\n",
            "  Downloading roman-3.3-py2.py3-none-any.whl (3.9 kB)\n",
            "Installing collected packages: roman\n",
            "Successfully installed roman-3.3\n"
          ]
        }
      ]
    },
    {
      "cell_type": "code",
      "execution_count": 2,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "zE_5cij5Q0gD",
        "outputId": "ae4992a2-ccc9-45a9-f730-8afe570dfa3b"
      },
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "Drive already mounted at /content/drive; to attempt to forcibly remount, call drive.mount(\"/content/drive\", force_remount=True).\n"
          ]
        }
      ],
      "source": [
        "from google.colab import drive\n",
        "drive.mount('/content/drive')"
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "# name_list = [\n",
        "#     # 'ZogenixInc_20190509_10-Q_EX-10.2_11663313_EX-10.2_Distributor Agreement',\n",
        "#     # 'PerformanceSportsBrandsInc_20110909_S-1_EX-10.10_7220214_EX-10.10_Endorsement Agreement',\n",
        "#     # 'OTISWORLDWIDECORP_04_03_2020-EX-10.4-INTELLECTUAL PROPERTY AGREEMENT by and among UNITED TECHNOLOGIES CORPORATION, OTIS WORLDWIDE CORPORATION and CARRIER ~1',\n",
        "#     # 'NUVEEN - REMARKETING AGREEMENT',\n",
        "#     # 'ParatekPharmaceuticalsInc_20170505_10-KA_EX-10.29_10323872_EX-10.29_Outsourcing Agreement',\n",
        "#     # 'vertex.html',\n",
        "#     'AimmuneTherapeuticsInc_20200205_8-K_EX-10.3_11967170_EX-10.3_Development Agreement',\n",
        "#     'AtnInternationalInc_20191108_10-Q_EX-10.1_11878541_EX-10.1_Maintenance Agreement',\n",
        "#     'FOUNDATIONMEDICINE,INC_02_02_2015-EX-10.2-Collaboration Agreement',\n",
        "#     'FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement',\n",
        "#     'GarrettMotionInc_20181001_8-K_EX-2.4_11364532_EX-2.4_Intellectual Property Agreement'\n",
        "# ]\n",
        "# toc_lists = [\n",
        "    \n",
        "#     # # ZogenixInc_20190509_10-Q_EX-10.2_11663313_EX-10.2_Distributor Agreement\n",
        "#     # [['Article 1. Definitions'], ['Article 2. Grant of Rights'], ['2.1', 'Grant of Rights to Distributor'], ['2.2', 'Sub-distribution by Distributor'], ['2.3', 'Supply of Product for Distributorship'], ['2.4', 'No Other Rights; Other Limitations'], ['2.5', 'Non-Compete Covenant'], ['2.6', 'No Activities Outside the Territory or Field'], ['Article 3. Governance'], ['3.1', 'Joint Steering Committee'], ['3.2', 'Expenses'], ['3.3', 'Alliance Managers'], ['3.4', 'Scope of Governance'], ['Article 4. Development and Regulatory Activities'], ['4.1', 'Nonclinical and Clinical Studies and CMC Requirements'], ['4.2', 'Regulatory Activities'], ['4.3', 'Distributors Right to Use and Reference'], ['4.4', 'Zogenixs Right to Use and Reference'], ['4.5', 'Adverse Event Reporting'], ['4.6', 'Drug Safety and Pharmacovigilance System including Global Safety Database'], ['4.7', 'Regulatory Audit'], ['4.8', 'Use of Subcontractors'], ['4.9', 'Recalls'], ['4.1', 'Development Expenses'], ['Article 5. Commercialization; Supply: Trademarks'], ['5.1', 'Commercialization of the Product.'], ['5.2', 'Supply'], ['5.3', 'Trademark Rights'], ['5.4', 'Commercial Expenses'], ['Article 6. Payments'], ['6.1', 'Upfront Payment'], ['6.2', 'Funding to Support Development of The Product'], ['6.3', 'Regulatory Milestones'], ['6.4', 'Sales Milestones'], ['6.5', 'Supply Payments'], ['Article 7. Payments, Books and Records'], ['7.1', 'Payment Method']], \n",
        "#     # # PerformanceSportsBrandsInc_20110909_S-1_EX-10.10_7220214_EX-10.10_Endorsement Agreement\n",
        "#     # [['Paragraph', 'Page'], ['1.', 'Definitions', '3'], ['2.', 'Term', '4'], ['3.', 'Grant of License and Exclusivity', '4'], ['4.', 'Retention of Rights', '4'], ['5.', 'Appearances', '4'], ['6.', 'Compensation', '5'], ['7.', 'Supply of Endorsed Products', '6'], ['8.', 'Approval of Advertising', '7'], ['9.', 'Ownership', '8'], ['10.', 'SAG and/or AFTRA', '8'], ['11.', 'Standards', '8'], ['12.', 'Events of Default', '8'], ['13.', 'Termination/Remedies', '9'], ['14.', 'Companys Debts', '9'], ['15.', 'Indemnification', '9'], ['16.', 'Insurance', '9'], ['17.', 'Waiver', '9'], ['18.', 'Notices', '10'], ['19.', 'Assignment', '10'], ['20.', 'Independent Contractor', '10'], ['21.', 'Joint Venture', '10'], ['22.', 'Governing Law', '10'], ['23', 'Entire Agreement', '10'], ['24.', 'Amendments', '10'], ['25.', 'Authority', '11'], ['26.', 'Severability', '11'], ['27.', 'Compliance with Laws', '11'], ['28.', 'Attorneys Fees and Costs', '11'], ['29.', 'Force Majeure', '11'], ['30.', 'Confidentiality', '11'], ['31.', 'Counterparts', '11']],\n",
        "#     # # OTISWORLDWIDECORP_04_03_2020-EX-10.4-INTELLECTUAL PROPERTY AGREEMENT by and among UNITED TECHNOLOGIES CORPORATION, OTIS WORLDWIDE CORPORATION and CARRIER ~1\n",
        "#     # [['ARTICLE I DEFINITIONS', '2'], ['1.1', 'Defined Terms', '2'], ['ARTICLE II ASSIGNMENT OF SOLELY OWNED INTELLECTUAL PROPERTY RIGHTS', '7'], ['2.1', 'Assigned Intellectual Property Rights', '7'], ['ARTICLE III LICENSING OF INTELLECTUAL PROPERTY RIGHTS', '8'], ['3.1', 'Licensed Intellectual Property Rights', '8'], ['3.2', 'Reserved Intellectual Property Rights', '10'], ['3.3', 'No Rescission', '10'], ['ARTICLE IV TRADEMARKS', '10'], ['4.1', 'Ownership of United Technologies Trademarks', '10'], ['4.2', 'Use of United Technologies Trademarks', '11'], ['4.3', 'Special Trademark Provisions.', '12'], ['ARTICLE V EXCLUDED AGREEMENTS', '12'], ['5.1', 'No Change to Excluded Agreements', '12'], ['ARTICLE VI CONFIDENTIALITY', '12'], ['6.1', 'Received Information and Materials', '12'], ['6.2', 'Confidential Information', '12'], ['6.3', 'Obligations', '13'], ['6.4', 'Termination of UTC NDA', '13'], ['ARTICLE VII LIMITATIONS AND DISCLAIMERS', '13'], ['7.1', 'Subsequent Delivery of Intellectual Property Rights', '13'], ['7.2', 'No Additional Obligations', '14'], ['7.3', 'DISCLAIMER', '14'], ['7.4', 'Limitations of Liability', '14'], ['ARTICLE VIII GOVERNING LAW AND DISPUTE RESOLUTION', '15'], ['8.1', 'Governing Law', '15'], ['8.2', 'Alternative Dispute Resolution', '15'], ['8.3', 'Confidentiality', '13'], ['8.4', 'Equitable Relief', '13']],\n",
        "#     # # NUVEEN - REMARKETING AGREEMENT\n",
        "#     # [['Page'], ['Section1.', 'Definitions', '1'], ['Section2.', 'Appointment and Obligations of the Remarketing Agent', '3'], ['Section3.', 'Representations, Warranties and Covenants of the Remarketing Agent and the Fund', '6'], ['Section4.', 'Fees and Expenses', '7'], ['Section5.', 'Resignation, Suspension and Removal of the Remarketing Agent', '7'], ['Section6.', 'Dealing in the VRRM-MFP Shares', '8'], ['Section7.', 'Information', '8'], ['Section8.', 'Conditions to Obligations of the Remarketing Agent', '9'], ['Section9.', 'Indemnification', '10'], ['Section10.', 'Termination of Remarketing Agreement', '13'], ['Section11.', 'Remarketing Agents Performance; Duty of Care', '13'], ['Section12.', 'Amendment, Supplement or Modification of Agreements', '13'], ['Section13.', 'Books and Records', '14'], ['Section14.', 'Governing Law', '14'], ['Section15.', 'Waiver of Jury Trial', '14'], ['Section16.', 'Certain Provisions to Survive Termination of Agreement', '14'], ['Section17.', 'Successors and Assigns', '14'], ['Section18.', 'Headings', '15'], ['Section19.', 'Severability', '15'], ['Section20.', 'Counterparts', '15'], ['Section21.', 'Remarketing Agent Not Acting as Underwriter', '15'], ['Section22.', 'Amendment', '15']],\n",
        "#     # # ParatekPharmaceuticalsInc_20170505_10-KA_EX-10.29_10323872_EX-10.29_Outsourcing Agreement\n",
        "#     # [['Article 1', 'Interpretation', '6'], ['1.1', 'Definitions', '6'], ['1.2', 'Other Definitions', '10'], ['1.3', 'Currency', '10'], ['1.4', 'Headings', '10'], ['1.5', 'Exhibits', '10'], ['1.6', 'Applicable Law', '10'], ['Article 2', 'Term', '10'], ['2.1', 'Term'], ['2.2', 'Effect of Expiration on Purchase Orders', '11'], ['Article 3', 'Supply of Product', '11'], ['3.1', 'Supply of Product'], ['3.2', 'Manufacturing Services', '12'], ['3.3', 'Supply of Materials and Customer Material', '12'], ['3.4', 'Production Capacity', '14'], ['3.5', 'Processing Changes', '14'], ['3.6', 'Monitoring of Facilities', '14'], ['3.7', 'Subcontracting', '15'], ['3.8', '[* * *]'], ['3.9', '[* * *]'], ['3.1', 'Territory Expansion', '15'], ['3.11', 'Supply to Customer Licensees', '16'], ['3.12', 'Alternative Supply', '16'], ['Article 4', 'Forecasts', '16'], ['4.1', 'Short Term Rolling Forecasts', '16'], ['4.2', 'Long Term Forecasts', '17'], ['Article 5', 'Testing and Samples', '17'], ['5.1', 'Release Testing', '17'], ['5.2', 'Additional Release Testing', '18'], ['5.3', 'Retention Samples', '18'], ['5.4', 'Stability Testing', '18'], ['5.5', 'Reference Standards', '18']],\n",
        "#     # # vertex.html\n",
        "#     # [[\"ARTICLE I DEFINITIONS\", \"1\"], [\"ARTICLE II PURCHASE AND SALE\", \"12\"], [\"Section 2.01 Purchase and Sale of Assets\", \"12\"], [\"Section 2.02 Assumed Liabilities\", \"14\"], [\"Section 2.03 Excluded Liabilities\", \"14\"], [\"Section 2.04 Purchase Price\", \"15\"], [\"Section 2.05 Purchase Price Adjustments\", \"16\"], [\"Section 2.06 Withholding Tax; Allocation\", \"18\"], [\"Section 2.07 Third Party Consents\", \"18\"], [\"ARTICLE III CLOSING\", \"18\"], [\"Section 3.01 Closing\", \"18\"], [\"Section 3.02 Closing Deliverables\", \"19\"], [\"ARTICLE IV REPRESENTATIONS AND WARRANTIES OF SELLER PARTIES\", \"20\"], [\"Section 4.01 Organization and Qualification of Seller Parties\", \"20\"], [\"Section 4.02 Authority of Seller Parties\", \"21\"], [\"Section 4.03 No Conflicts; Consents\", \"21\"], [\"Section 4.04 Financial Statements\", \"22\"], [\"Section 4.05 Undisclosed Liabilities\", \"22\"], [\"Section 4.06 Material Contracts\", \"23\"], [\"Section 4.07 Title to Purchased Assets\", \"24\"], [\"Section 4.08 Condition and Sufficiency of Assets\", \"24\"], [\"Section 4.09 The Properties\", \"24\"], [\"Section 4.10 Customers and Suppliers\", \"26\"], [\"Section 4.11 Insurance\", \"27\"], [\"Section 4.12 Legal Proceedings; Governmental Orders\", \"27\"], [\"Section 4.13 Compliance With Laws; Permits\", \"27\"]],\n",
        "#     # AimmuneTherapeuticsInc_20200205_8-K_EX-10.3_11967170_EX-10.3_Development Agreement\n",
        "#     [['Page'], ['ARTICLE 1 Definitions', '1'], ['ARTICLE 2 Licenses', '13'], ['ARTICLE 3 Development', '16'], ['ARTICLE 4 Regulatory', '17'], ['ARTICLE 5 Commercialization', '19'], ['ARTICLE 6 Supply', '20'], ['ARTICLE 7 Payments', '21'], ['ARTICLE 8 Payment; Records; Audits', '24'], ['ARTICLE 9 Intellectual Property Matters', '26'], ['ARTICLE 10 Representations, Warranties and Covenants; Compliance', '31'], ['ARTICLE 11 Indemnification', '34'], ['ARTICLE 12 Confidentiality', '36'], ['ARTICLE 13 Term and Termination', '40'], ['ARTICLE 14 Effects of Expiration Or Termination', '40'], ['ARTICLE 15 Miscellaneous', '43'], ['Schedule 1.10 Antibody', '50'], ['Schedule 1.79 Xencor General Patents', '51'], ['Schedule 1.81 Xencor Product Specific Patents', '52'], ['Schedule 2.7 Xencor Know-How, Regulatory Materials, and\\nRegulatory Data', '53'], ['Schedule 6.1 Initial Product Supply', '54'], ['Schedule 10.2.6 Exceptions', '55'], ['Schedule 12.2 Initial Press Release', '56']],\n",
        "#     # AtnInternationalInc_20191108_10-Q_EX-10.1_11878541_EX-10.1_Maintenance Agreement\n",
        "#     [['Page'], ['1.1Scope', '1'], ['1.2', 'Scope of Agreement', '1'], ['1.3', 'Term of Agreement', '1'], ['2.1Definitions', '1'], ['2.2', 'Affiliate', '1'], ['2.3', 'Agreement', '2'], ['2.4', 'Attorneys Fees', '2'], ['2.5', 'AT&T Competitor', '2'], ['2.6', 'AT&T Indemnified Parties', '2'], ['2.7', 'Cell Site', '2'], ['2.8', 'Change Management Plan', '2'], ['2.9', 'Change of Control', '2'], ['2.10', 'Change Order', '2'], ['2.11', 'Control', '2'], ['2.12', 'Customer Information', '3'], ['2.13', 'Deliverable', '3'], ['2.14', 'Delivery or Completion', '3'], ['2.15', 'Delivery Date or Completion Date', '3'], ['2.16', 'Documentation', '4'], ['2.17', 'Drug Screen', '4'], ['2.18', 'Employment Claims', '4'], ['2.19', 'Excusable Delay', '4'], ['2.20', 'FirstNet Authority', '4'], ['2.21', 'Information', '5'], ['2.22', 'Intellectual Property Rights', '5'], ['2.23', 'Items', '5'], ['2.24', 'Laws', '5'], ['2.25', 'Liability', '5'], ['2.26', 'Lien', '5'], ['2.27', 'Litigation Expense', '5'], ['2.28', 'Loss', '5'], ['2.29', 'Material', '6'], ['2.30', 'Non-Service Affecting Defect', '6'], ['2.31', 'OEM', '6'], ['2.32', 'Permits', '6'], ['2.33', 'Person', '6'], ['2.34', 'Physical Entry', '6'], ['2.35', 'Restricted Entities', '6'], ['2.36', 'Service Affecting Defect', '7'], ['2.37', 'Services', '7']],\n",
        "#     # FOUNDATIONMEDICINE,INC_02_02_2015-EX-10.2-Collaboration Agreement\n",
        "#     [['1.', 'Definitions', '7'], ['1.1', 'Affiliate', '7'], ['1.2', 'Agreement', '7'], ['1.3', 'Agreement Term', '7'], ['1.4', '[...***...] ctDNA [...***...]', '7'], ['1.5', 'Applicable Law', '7'], ['1.6', 'Approved Assay', '7'], ['1.7', 'Background IP', '7'], ['1.8', 'Business Day', '8'], ['1.9', 'Calendar Half', '8'], ['1.10', 'Calendar Quarter', '8'], ['1.11', 'Calendar Year', '8'], ['1.12', 'CDx', '8'], ['1.13', 'CDx Development Program', '8'], ['1.14', 'CLIA', '8'], ['1.15', 'Clinical Study', '9'], ['1.16', 'Commercially Reasonable Efforts', '9'], ['1.17', 'Confidential Information', '9'], ['1.18', 'Control', '9'], ['1.19', 'Cover', '10'], ['1.20', 'ctDNA', '10'], ['1.21', 'ctDNA Assay', '10'], ['1.22', 'ctDNA Platform', '10'], ['1.23', 'ctDNA Platform Development Program', '10'], ['1.24', 'ctDNA Working Group', '10'], ['1.25', 'Data Security Breach', '10'], ['1.26', 'Effective Date', '10'], ['1.27', 'Excepted Activities', '11'], ['1.28', 'Excluded Patent Rights', '11'], ['1.29', 'FDA', '11'], ['1.30', 'FDCA', '11'], ['1.31', 'FMI Background IP Patent Rights', '11'], ['1.32', 'FMI Decisions', '11'], ['1.33', 'FMI Development Costs', '11'], ['1.34', 'FMI Know-How', '11'], ['1.35', 'FMI Foreground Patent Rights', '12'], ['1.36', 'FTE', '12'], ['1.37', 'FTE Rate', '12'], ['1.38', 'Handle', '12'], ['1.39', 'HSR', '12'], ['1.40', 'Immunotherapy Testing Platform Development Program', '12'], ['1.41', 'Immuno-Platform Working Group', '12'], ['1.42', 'Initiation', '12'], ['1.43', 'Insolvency Event', '12'], ['1.44', 'Invention', '13'], ['1.45', 'IUO', '13'], ['1.46', 'JMC', '13'], ['1.47', 'JOC', '13'], ['1.48', 'Joint Know-How', '13'], ['1.49', 'Joint Patent Rights', '13']],\n",
        "#     # FuelcellEnergyInc_20191106_8-K_EX-10.1_11868007_EX-10.1_Development Agreement\n",
        "#     [['ARTICLE 1  DEFINITIONS', '1'], ['ARTICLE 2  PROGRAM', '1'], ['ARTICLE 3  PROGRAM GOVERNANCE', '2'], ['ARTICLE 4  DISCLOSURE, CONFIDENTIALITY AND RESTRICTED USE', '3'], ['ARTICLE 5  PUBLICITY AND PUBLICATIONS', '5'], ['ARTICLE 6  OWNERSHIP / PROCUREMENT OF PROGRAM RESULTS', '6'], ['ARTICLE 7 LICENSE TO PROGRAM RESULTS', '7'], ['ARTICLE 8  LICENSE TO BACKGROUND INFORMATION AND PATENTS', '8'], ['ARTICLE 9  INFRINGEMENT OF THIRD PARTY PATENTS', '11'], ['ARTICLE 10  PAYMENT', '11'], ['ARTICLE 11  REPRESENTATIONS, WARRANTIES, INDEMNITIES AND LIABILITIES', '13'], ['ARTICLE 12  TERM AND TERMINATION', '14'], ['ARTICLE 13  ARBITRATION AND GOVERNING LAW', '17'], ['ARTICLE 14  ASSIGNMENT', '18'], ['ARTICLE 15  FORCE MAJEURE', '18'], ['ARTICLE 16  ADDRESSES AND NOTICES', '18'], ['ARTICLE 17  COMPLIANCE', '19'], ['ARTICLE 18  RECORDS AND AUDIT', '20'], ['ARTICLE 19  TAXES', '20'], ['ARTICLE 20  ADDITIONAL PROVISIONS', '20'], ['APPENDIX A  DEFINITIONS', '24'], ['APPENDIX B  SAMPLE PROJECT DESCRIPTION FORMAT', '30']],\n",
        "#     # GarrettMotionInc_20181001_8-K_EX-2.4_11364532_EX-2.4_Intellectual Property Agreement\n",
        "#     [['Page'], ['ARTICLE I'], ['DEFINITIONS'], ['Section 1.01.', 'Definitions', '1'], ['ARTICLE II'], ['RECORDATION OF INTELLECTUAL PROPERTY RIGHTS ASSIGNMENT AGREEMENTS'], ['Section2.01.', 'Intellectual Property Assignment Agreements', '4'], ['Section2.02.', 'Recordation', '4'], ['Section2.03.', 'Security Interests', '4'], ['ARTICLE III'], ['LICENSES AND COVENANTS FROM HONEYWELL TO SPINCO'], ['Section3.01.', 'License Grants', '4'], ['Section3.02.', 'Other Covenants', '5'], ['Section3.03.', 'Honeywell Content', '6'], ['ARTICLE IV'], ['LICENSES AND COVENANTS FROM SPINCO TO HONEYWELL'], ['Section4.01.', 'License Grants', '7'], ['Section4.02.', 'Other Covenants', '7'], ['ARTICLE V'], ['ADDITIONAL INTELLECTUAL PROPERTY RELATED MATTERS'], ['Section5.01.', 'Assignments and Licenses', '8'], ['Section5.02.', 'No Implied Licenses', '9'], ['Section5.03.', 'No Obligation To Prosecute or Maintain Patents', '9'], ['Section5.04.', 'Technical Assistance', '9'], ['Section5.05.', 'Group Members', '9'], ['Section5.06.', 'R&D Projects', '9'], ['ARTICLE VI'], ['CONFIDENTIAL INFORMATION'], ['Section6.01.', 'Confidentiality', '9']]\n",
        "\n",
        "# ]\n"
      ],
      "metadata": {
        "id": "ltQc1S2oSXM2"
      },
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [
        "# Main code starts here. \n",
        "# TODO: Convert into a function that takes in dict of TOCs and extracts the labels.\n",
        "\n",
        "import json\n",
        "with open('/content/scraping_results.json', 'r') as f:\n",
        "  scraping_results = json.load(f)\n"
      ],
      "metadata": {
        "id": "VAdP13eGwUfs"
      },
      "execution_count": 11,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [
        "# Add in your own file path to the dict for future use\n",
        "# user_file_paths = {'Rohith': '/content/drive/MyDrive/CDS Capstone Project/cuad_htmls'}"
      ],
      "metadata": {
        "id": "VIKihyIMSamb"
      },
      "execution_count": 12,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [
        "# toc_lists = toc_lists[3:]"
      ],
      "metadata": {
        "id": "9F2g9JXgMe0x"
      },
      "execution_count": 13,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [
        "from pprint import pprint\n",
        "scraping_results.keys()"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "Ix_BPJjo30Qh",
        "outputId": "e3df9650-5d36-4c1f-e1a5-058381f68ce0"
      },
      "execution_count": 14,
      "outputs": [
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "dict_keys(['ZogenixInc_20190509_10-Q_EX-10.2_11663313_EX-10.2_Distributor Agreement.html', 'PerformanceSportsBrandsInc_20110909_S-1_EX-10.10_7220214_EX-10.10_Endorsement Agreement.html', 'HarpoonTherapeuticsInc_20200312_10-K_EX-10.18_12051356_EX-10.18_Development Agreement.html', 'NUVEEN - REMARKETING AGREEMENT.html', 'OTISWORLDWIDECORP_04_03_2020-EX-10.4-INTELLECTUAL PROPERTY AGREEMENT by and among UNITED TECHNOLOGIES CORPORATION, OTIS WORLDWIDE CORPORATION and CARRIER ~1.html', 'ParatekPharmaceuticalsInc_20170505_10-KA_EX-10.29_10323872_EX-10.29_Outsourcing Agreement.html'])"
            ]
          },
          "metadata": {},
          "execution_count": 14
        }
      ]
    },
    {
      "cell_type": "markdown",
      "source": [
        "Split the extracted TOC by sections, and then subsections. Each section will have it's own dictionary entry. Any subsections become entries into another dictionary under the section. i.e., {'1':('Article 1', {'1', '1.1 Terms'}), '2':'Article 2'} \n",
        "\n",
        "\n",
        "The exact outputs are a dictionary of string:tuple(string, dict) or string:string."
      ],
      "metadata": {
        "id": "er2kPnouzRdY"
      }
    },
    {
      "cell_type": "code",
      "source": [
        "# For a single toc extraction, output a file in a specified output folder\n",
        "import re\n",
        "import roman\n",
        "from pprint import pprint\n",
        "import json\n",
        "import os\n",
        "\n",
        "def extract_label_to_json(toc_extracted, output_dir):\n",
        "  contract_title = toc_extracted[0]\n",
        "  toc = toc_extracted[1]\n",
        "\n",
        "  label_dict = {}\n",
        "  n_section = 1\n",
        "  n_subsection = 1\n",
        "\n",
        "  ### Roman Numeral Check\n",
        "  roman_numerals = ['II', 'III', 'IV', 'VII', 'VIII', 'IX', 'XI', 'XII']\n",
        "  numeral_counter = 0\n",
        "  is_roman = False\n",
        "\n",
        "  for item in toc:\n",
        "    if numeral_counter >= 2:\n",
        "      is_roman = True\n",
        "      break\n",
        "    is_subsection = re.search('\\d\\.(\\d)+', item[0])\n",
        "    if not is_subsection:\n",
        "      if any(romans in item[0] for romans in roman_numerals):\n",
        "        numeral_counter += 1\n",
        "\n",
        "  ### Label Extraction\n",
        "  for item in toc:\n",
        "    # Section number regex rules to handle improperly ordered inputs\n",
        "    if re.search('\\.(\\d\\d) \\n\\d', item[0]):\n",
        "      item[0] = item[0][-2:] + item[0][1:3]\n",
        "    if re.search('\\.(\\d\\d)(\\n)+\\d', item[0]):\n",
        "      item[0] = item[0][-2:] + item[0][1:3]\n",
        "    if re.search('\\.(\\d)+ [\\D]+ \\d\\.', item[0]):\n",
        "      item[0] = item[0][-2:] + item[0][1:-2]\n",
        "    \n",
        "    # Determine if line is a subsection using regex\n",
        "    is_subsection = re.search('(\\d)+\\.(\\d)+', item[0])\n",
        "    # print(item)\n",
        "    if re.search('\\d\\.0', item[0]):\n",
        "      is_subsection = False\n",
        "    \n",
        "    if not is_subsection:\n",
        "      n_section_str = roman.toRoman(n_section) if is_roman else f'{n_section}'\n",
        "\n",
        "      if n_section_str in item[0]:\n",
        "        section_title = item[0]\n",
        "\n",
        "        if len(item) > 1:\n",
        "          try:\n",
        "            int(item[1]) \n",
        "          except:\n",
        "            section_title = f'{section_title} {item[1]}'\n",
        "        \n",
        "        label_dict[n_section] = (section_title, {})\n",
        "        n_section += 1\n",
        "        n_subsection = 1\n",
        "\n",
        "    else:\n",
        "      # Is a section title with d.d style numbering\n",
        "      # print(item)\n",
        "      if len(item) == 2:\n",
        "\n",
        "        section_title = ' '.join(re.split('(\\d\\.\\d+)', item[0])).strip() \n",
        "        label_dict[n_section] = (section_title + ' ' + item[1], {})\n",
        "        n_section += 1\n",
        "      # Is an actual subsection\n",
        "      else:\n",
        "        # print(n_section, n_subsection, is_subsection.group(), item, contract_title)\n",
        "        concat_items = ' '.join(item[1:])\n",
        "        label_dict[n_section-1][1][n_subsection] = (f'{is_subsection.group()} {concat_items}', {})\n",
        "        \n",
        "      n_subsection += 1\n",
        "\n",
        "  # labels_title = '/' + contract_title[:contract_title.find('_')]\n",
        "  with open(contract_title, 'w') as f:\n",
        "    json.dump(label_dict, f)\n",
        "  return contract_title, label_dict\n",
        "\n",
        "# sample_toc = ('SoupmanInc_20150814_8-K_EX-10.1_9230148_EX-10.1_Franchise Agreement1.html', scraping_results['SoupmanInc_20150814_8-K_EX-10.1_9230148_EX-10.1_Franchise Agreement1.html'])\n",
        "a= True\n",
        "for item in scraping_results.items():\n",
        "  if a:\n",
        "    a = False\n",
        "    continue\n",
        "  sample_toc = item\n",
        "  break\n",
        "pprint(sample_toc)\n",
        "extract_label_to_json(sample_toc, '/content')\n",
        "# sample_toc"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "qpw6SlRcateV",
        "outputId": "988bfbc0-d901-478a-d7df-b7484a69f62b"
      },
      "execution_count": 15,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "('PerformanceSportsBrandsInc_20110909_S-1_EX-10.10_7220214_EX-10.10_Endorsement '\n",
            " 'Agreement.html',\n",
            " [['Paragraph', 'Page'],\n",
            "  ['1.', 'Definitions', '3'],\n",
            "  ['2.', 'Term', '4'],\n",
            "  ['3.', 'Grant of License and Exclusivity', '4'],\n",
            "  ['4.', 'Retention of Rights', '4'],\n",
            "  ['5.', 'Appearances', '4'],\n",
            "  ['6.', 'Compensation', '5'],\n",
            "  ['7.', 'Supply of Endorsed Products', '6'],\n",
            "  ['8.', 'Approval of Advertising', '7'],\n",
            "  ['9.', 'Ownership', '8'],\n",
            "  ['10.', 'SAG and/or AFTRA', '8'],\n",
            "  ['11.', 'Standards', '8'],\n",
            "  ['12.', 'Events of Default', '8'],\n",
            "  ['13.', 'Termination/Remedies', '9'],\n",
            "  ['14.', 'Companys Debts', '9'],\n",
            "  ['15.', 'Indemnification', '9'],\n",
            "  ['16.', 'Insurance', '9'],\n",
            "  ['17.', 'Waiver', '9'],\n",
            "  ['18.', 'Notices', '10'],\n",
            "  ['19.', 'Assignment', '10'],\n",
            "  ['20.', 'Independent Contractor', '10'],\n",
            "  ['21.', 'Joint Venture', '10'],\n",
            "  ['22.', 'Governing Law', '10'],\n",
            "  ['23', 'Entire Agreement', '10'],\n",
            "  ['24.', 'Amendments', '10'],\n",
            "  ['25.', 'Authority', '11'],\n",
            "  ['26.', 'Severability', '11'],\n",
            "  ['27.', 'Compliance with Laws', '11'],\n",
            "  ['28.', 'Attorneys Fees and Costs', '11'],\n",
            "  ['29.', 'Force Majeure', '11'],\n",
            "  ['30.', 'Confidentiality', '11'],\n",
            "  ['31.', 'Counterparts', '11'],\n",
            "  ['1.',\n",
            "   'Definitions. As used herein, the following terms shall be defined as set '\n",
            "   'forth below:'],\n",
            "  ['a.',\n",
            "   'Contract Period shall mean that period of time from February 21, 2011 '\n",
            "   'through December 31, 2012.'],\n",
            "  ['b.',\n",
            "   'Contract Year shall mean the specific period of time during the Contract '\n",
            "   'Period as more specifically set forth below:'],\n",
            "  ['Contract Year 2011 (2/21/11 - 12/31/11)'],\n",
            "  ['Contract Year 2012 (1/1/12- 12/31/12)'],\n",
            "  ['c.', 'Contract Territory shall mean the world.'],\n",
            "  ['d.',\n",
            "   'Norths Likeness shall mean and include Norths name, image, photograph, '\n",
            "   'voice, initials, signature, biographical information, and persona.'],\n",
            "  ['f.',\n",
            "   'Norths Endorsement shall mean and include Norths public statements and '\n",
            "   'comments about Companys Product.'],\n",
            "  ['g.',\n",
            "   'Endorsed Product(s) shall only mean and include Companys irons, woods, '\n",
            "   'wedges and putters.'],\n",
            "  ['2.',\n",
            "   'Term. The Term of this Agreement shall be for the Contract Period unless '\n",
            "   'it is terminated or extended as set forth in this Agreement.'],\n",
            "  ['3.',\n",
            "   'Grant of License and Exclusivity. Subject to the terms set forth in this '\n",
            "   'Agreement, North hereby grants to Company the right and privilege to use '\n",
            "   'Norths Likeness and Norths Endorsement during the Term and within the '\n",
            "   'Contract Territory in all reasonable forms of advertising including, but '\n",
            "   'not limited to television (including the infomercial format), radio, print '\n",
            "   'advertising, brochures, pamphlets, product packaging, point-of-purchase '\n",
            "   'materials, Companys web-site and a demonstration video (hereinafter '\n",
            "   'referred to as Advertising Materials) in connection with Companys '\n",
            "   'advertisement and sale of the Endorsed Product only. During the Term of '\n",
            "   'this Agreement and within the Contract Territory, North agrees not to '\n",
            "   'enter into an agreement with another company or entity for the purpose of '\n",
            "   'endorsing or promoting products similar to the Endorsed Products. Upon the '\n",
            "   'expiration or termination of this Agreement, Company shall be prohibited '\n",
            "   'from using or distributing any new or existing Advertising Materials using '\n",
            "   'Norths Likeness and Norths Endorsement except for Endorsed Product with '\n",
            "   'Norths Likeness and/or Norths Endorsement on the packaging that is already '\n",
            "   'in the channel of retail distribution. Company shall be prohibited from '\n",
            "   'selling or shipping any new Endorsed Product with Norths Likeness and/or '\n",
            "   'Norths Endorsement on the packaging upon the expiration or termination of '\n",
            "   'this Agreement.'],\n",
            "  ['4.',\n",
            "   'Retention of Rights. All rights not specifically granted or licensed to '\n",
            "   'Company hereunder shall be reserved and retained by North and may be '\n",
            "   'utilized or licensed by North to any third parties in any manner which is '\n",
            "   'not in contravention of this Agreement.'],\n",
            "  ['5.', 'Appearances.'],\n",
            "  ['a.', 'Production Appearances.'],\n",
            "  ['i.',\n",
            "   'Contract Year 2011. North agrees to make one (1) Production Appearance on '\n",
            "   'behalf of Company during Contract Year 2011 for the purpose of producing '\n",
            "   'the following: (1) one 30-minute infomercial; (2) one 30-second television '\n",
            "   'commercial; (3) one demonstration dvd on how to use the Endorsed Product. '\n",
            "   '(4) product testimonials and (5) still photographs for print '\n",
            "   'advertisements and packaging (hereinafter referred to as Production '\n",
            "   'Appearance). Said Production Appearance shall take place on February 22 & '\n",
            "   '23, 2011 in or around Phoenix, AZ. The Production Appearance shall be '\n",
            "   'approximately nine (9) hours in duration on February 22nd and five (5) '\n",
            "   'hours in duration on February 23rd. During such Production Appearance, '\n",
            "   'North shall be permitted to wear the apparel of his choice.'],\n",
            "  ['ii.',\n",
            "   'Contract Year 2012. North agrees to make one (1) Production Appearance on '\n",
            "   'behalf of Company during Contract Year 2012 for the purpose of producing '\n",
            "   'either new or updated Advertising Materials. Said Production Appearance '\n",
            "   'shall take place at a mutually agreed upon time and location.The '\n",
            "   'Production Appearance shall be approximately nine (9) hours in duration on '\n",
            "   'the first day and five (5) hours in duration on the second day. During '\n",
            "   'such Production Appearance, North shall be permitted to wear the apparel '\n",
            "   'of his choice.'],\n",
            "  ['b.',\n",
            "   'Additional Production/Promotional Appearances. If requested by Company, '\n",
            "   'North agrees to use reasonable effort to make Additional '\n",
            "   'Production/Promotional Appearances on behalf of Company (hereinafter '\n",
            "   'referred to as Additional Production/Promotional Appearances). Should '\n",
            "   'Company request for North to conduct Additional Production/Promotional '\n",
            "   'Appearances and North agrees to appear, Company shall pay North an '\n",
            "   'additional fee for such appearance(s) as set forth in paragraph 6.d. '\n",
            "   'below. North has no obligation to make such appearance.'],\n",
            "  ['c.',\n",
            "   'Voice-Over Appearances. If requested by Company, North shall make one (1) '\n",
            "   'voice over appearance during the Term. The voice over appearance shall '\n",
            "   'take place at Norths personal residence or at another mutually agreed upon '\n",
            "   'location in Wisconsin, and shall not exceed two (2) hours in duration.'],\n",
            "  ['d.',\n",
            "   'Promotional Appearance. If requested by Company, North agrees to make one '\n",
            "   '(1) promotional appearance each Contract Year during the Term at certain '\n",
            "   'events to promote the Endorsed Products. Said appearance shall be '\n",
            "   'approximately three (3) hours in duration.'],\n",
            "  ['e.',\n",
            "   'Promotion/Media Activities. North will use reasonable efforts to mention '\n",
            "   'the benefits of Companys Endorsed Products when North is being interviewed '\n",
            "   'or North is participating in Public Events as defined below.'],\n",
            "  ['f.',\n",
            "   'Expenses. If travel is necessary to provide the services set forth in this '\n",
            "   'Agreement, Company shall provide or reimburse all such travel expenses of '\n",
            "   'North, including round-trip first-class airfare on the airline of Norths '\n",
            "   'choice, first-class hotel accommodations, reasonable meal and ground '\n",
            "   'transportation expenses. Company shall deliver the airline tickets to '\n",
            "   'North at least seven (7) days prior to the scheduled appearance, and '\n",
            "   'reimburse North for other such expenses within ten (10) days after receipt '\n",
            "   'of the expense receipts.'],\n",
            "  ['g.',\n",
            "   'Scheduling. All appearances shall be scheduled on dates, times and '\n",
            "   'locations that are mutually agreed upon by Company and North. All such '\n",
            "   'appearances shall be scheduled through Norths duly authorized agent for '\n",
            "   'this projectFidelity Sports Group, LLC.'],\n",
            "  ['6.',\n",
            "   'Use of F2 Wedges/Using F2 Golf Bag. During the Contract Period and within '\n",
            "   'the Contract Territory, North agrees to:'],\n",
            "  ['a.',\n",
            "   'Wedges. Use Companys F2 branded wedges when competing professionally, '\n",
            "   'conducting public clinics or outings, participating in public golf events '\n",
            "   'and when appearing at other public functions where it is appropriate to '\n",
            "   'use or have golf clubs at such events (herein Public Events).'],\n",
            "  ['b.',\n",
            "   'Golf Bag. Use and carry Companys F2 branded golf bag at all Public Events '\n",
            "   'as defined immediately above. North shall have the right to place a '\n",
            "   'maximum of two (2) non-competitive third party sponsor names/logos that '\n",
            "   'are of a reasonable size on the belly portion of the F2 branded golf bag.'],\n",
            "  ['c.',\n",
            "   'Irons, Woods, Putter. Use reasonable efforts to use F2 branded irons, '\n",
            "   'woods and putter at all Public Events. For purposes of clarification, '\n",
            "   'North shall not be required to use F2 branded irons, woods and putters.'],\n",
            "  ['7.', 'Compensation.'],\n",
            "  ['a.',\n",
            "   'Guaranteed Service Fee and Marketing Retainer. In consideration for the '\n",
            "   'rights, services and benefits granted by North hereunder, Company agrees '\n",
            "   'to pay North a non-refundable Guaranteed Service Fee and Marketing '\n",
            "   'Retainer (hereinafter referred to as Guaranteed Fee) of fifty-five '\n",
            "   'thousand dollars ($55,000USD) in Contract Year 2011 and seventy thousand '\n",
            "   'dollars ($70,000USD) in Contract Year 2012.'],\n",
            "  ['(i)',\n",
            "   'Twenty-Five thousand dollars ($25,000USD) on or before two days after this '\n",
            "   'Agreement is fully executed.'],\n",
            "  ['(ii)', 'Fifteen thousand dollars ($15,000USD) on or before July 1, 2011.'],\n",
            "  ['(iii)',\n",
            "   'Fifteen thousand dollars ($ 15,000USD) on or before November 1, 2011.'],\n",
            "  ['(i)',\n",
            "   'Twenty-Five thousand dollars ($25,000USD) on or before February 1, 2012'],\n",
            "  ['(ii)',\n",
            "   'Twenty-Five thousand dollars ($25,000USD) on or before July 1, 2012'],\n",
            "  ['(iii)',\n",
            "   'Twenty thousand dollars ($20,000USD) on or before November 1, 2012'],\n",
            "  ['b.',\n",
            "   'Royalties. In addition to payments due North by Company as set forth in '\n",
            "   'paragraphs 7.a. above, Company further agrees to pay North a one percent '\n",
            "   '(1%) royalty on all Gross Revenue generated from the sale of all Company '\n",
            "   'Products (herein Royalties).'],\n",
            "  ['c.', 'Payment of Royalties/Statement of Accounts.'],\n",
            "  ['(i)',\n",
            "   'Company agrees to pay all royalties due as set forth in section 7.b. above '\n",
            "   'on or before thirty (30) days following the end of each quarterly period '\n",
            "   'during the Contract Period. The quarterly royalty payment shall be '\n",
            "   'accompanied by a statement of account indicating the quantities of '\n",
            "   'Products sold, the Gross Revenue generated from all sales of the Product '\n",
            "   'where the sales were derived from (i.e. direct sales or retail sales) and '\n",
            "   'the royalty payment that is due to North.'],\n",
            "  ['(ii)',\n",
            "   'Company shall keep, at its principal office, 1021 N. Sepulveda Blvd., '\n",
            "   'Suite G, Manhattan Beach, CA 90266, a complete and accurate set of books '\n",
            "   'and records maintained in accordance with generally accepted accounting '\n",
            "   'principles and business practices. Said books and records shall be '\n",
            "   'maintained for a two (2) year period following the expiration or '\n",
            "   'termination of this Agreement. Company shall make said books available to '\n",
            "   'North or Norths representative on reasonable notice during the Term of '\n",
            "   'this Agreement and the two (2) year period immediately following '\n",
            "   'thereafter. The cost of any and all inspections shall be paid by North, '\n",
            "   'unless an inspection shows an under-reporting or under-payment of more '\n",
            "   'than five-percent (5%) for any quarterly period, in which event Company '\n",
            "   'shall reimburse North for all such inspection costs.'],\n",
            "  ['d.',\n",
            "   'Additional Production/Promotional Appearances Fee. In addition to the '\n",
            "   'amounts payable by Company to North set forth in paragraph 7.a. and 7.b. '\n",
            "   'above, and should Company request for North to make Additional '\n",
            "   'Production/Promotional Appearances, Company further agrees to pay North a '\n",
            "   'mutually agreed upon fee for each Additional Production/Promotional '\n",
            "   'Appearance conducted by North. All compensation to be paid to North for '\n",
            "   'Additional Production/Promotional Appearances shall be due and payable to '\n",
            "   'North prior to each scheduled Additional Production/Promotional '\n",
            "   'Appearance.'],\n",
            "  ['e.',\n",
            "   'Form of Payment. All payments hereunder shall be made payable to the order '\n",
            "   'of Fidelity Sports Group, LLC, as agent for Andy North and shall be paid '\n",
            "   'via check or wire transfer. If by wire transfer, then direct payment to '\n",
            "   'the following bank account:'],\n",
            "  ['f.',\n",
            "   'Late Payments. Amounts not received within ten (10) days following their '\n",
            "   'respective due dates shall be assessed a late charge equal to one and '\n",
            "   'one-half percent (1 _%) per month of the overdue amount until paid, '\n",
            "   'commencing on the eleventh day.'],\n",
            "  ['g.',\n",
            "   'Supply of Endorsed Products. Company shall deliver to North, at no charge, '\n",
            "   'and in a timely fashion, a reasonable number of Endorsed Products for '\n",
            "   'Norths personal use each Contract Year during the Contract Period. All '\n",
            "   'postage expenses associated with the delivery of the Endorsed Products '\n",
            "   'shall be borne by Company.'],\n",
            "  ['8.', 'Approval of Advertising.'],\n",
            "  ['a.',\n",
            "   'Company agrees that it will not use Norths Likeness or Norths Endorsement '\n",
            "   'hereunder unless and until all Advertising Materials and their intended '\n",
            "   'use has been approved by North. North agrees that any Advertising '\n",
            "   'Materials submitted for approval as provided herein may be deemed by '\n",
            "   'Company to have been approved hereunder if the same is not disapproved by '\n",
            "   'North within seven (7) business days after receipt thereof. North agrees '\n",
            "   'that any Advertising Materials submitted hereunder will not be '\n",
            "   'unreasonably disapproved and, if it is disapproved, that Company will be '\n",
            "   'advised of the specific grounds for the disapproval. Company shall not use '\n",
            "   'such disapproved Advertising Materials until it has written approval from '\n",
            "   'North.'],\n",
            "  ['b.',\n",
            "   'Should Company utilize stock photographs of North, Company agrees to use '\n",
            "   'current photographs and not to add, delete, alter, amend or modify any '\n",
            "   'existing names, logos, designs, trademarks or other indicia of any other '\n",
            "   'sponsor of North which appear in the portion of the photograph used by '\n",
            "   'Company.'],\n",
            "  ['c.',\n",
            "   'Company acknowledges and agrees that the script and layout of the '\n",
            "   'Advertising Materials, including, but not limited to the infomercial, '\n",
            "   'shall be reasonably compatible with Norths personality and/or style. '\n",
            "   'Should the Advertising Materials be approved as set forth in Section 8.a. '\n",
            "   'above, the Advertising Materials shall reflect Norths personal experience '\n",
            "   'and/or testimonial concerning the Product. Such Advertising Material shall '\n",
            "   'be deemed to be Norths representation and warranty that such testimonial '\n",
            "   'copy in fact reflects Norths personal experience with and opinion of the '\n",
            "   'Endorsed Product.'],\n",
            "  ['9.',\n",
            "   'Ownership. All materials, in any form whatsoever, relating to the '\n",
            "   'Advertising Materials will be and shall remain the absolute property of '\n",
            "   'Company. North acknowledge that they do not now have and in the future '\n",
            "   'will assert no right, title, or interest of any kind or nature whatsoever, '\n",
            "   'in or to any component of the Advertising Materials. Furthermore, subject '\n",
            "   'to Norths approval as set forth in section 8 above, Company shall have the '\n",
            "   'right at any time during the Term of this Agreement to make any revisions '\n",
            "   'to the Advertising Materials or prepare versions of all or any part of the '\n",
            "   'Advertising Materials to conform to the requirements of individual markets '\n",
            "   'or customers.'],\n",
            "  ['10.',\n",
            "   'SAG and/or AFTRA. In the event of any of the Advertising Materials '\n",
            "   'contemplated herein come within the purview or jurisdiction of the Screen '\n",
            "   'Actors Guild (SAG) and/or the American Federation of Television and Radio '\n",
            "   'Artists (AFTRA), and North is required for any reason to become a member '\n",
            "   'thereof, North agrees to join such union(s), and Company agrees to pay any '\n",
            "   'and all expenses whatsoever including all dues, assessments, or '\n",
            "   'contributions necessary in order for North to render his services '\n",
            "   'hereunder, including any and all pension and health contributions or '\n",
            "   'assessments that may be required by such entities. Norths participation in '\n",
            "   'any such Advertising Materials pursuant to this paragraph in the Agreement '\n",
            "   'shall not result in any expenses or diminution of the Guaranteed Fee or '\n",
            "   'Royalties of this Endorsement Agreement whatsoever to North.'],\n",
            "  ['11.',\n",
            "   'Standards. Company and North shall at all times deal with each other in '\n",
            "   'good faith and strive to maintain and enhance each others positive image '\n",
            "   'and reputation. North and Company shall act at all times in a manner that '\n",
            "   'shall not be in contravention of public morals and conventions.'],\n",
            "  ['12.', 'Event of Default.'],\n",
            "  ['a.',\n",
            "   'It shall be an event of default hereunder by North if i) North shall '\n",
            "   'materially breach this Agreement and such breach remains uncured for a '\n",
            "   'period of thirty (30) days after written notice thereof from Company to '\n",
            "   'North, or ii) North shall be indicted for a felony involving moral '\n",
            "   'turpitude which brings disrepute to the Company.'],\n",
            "  ['b.',\n",
            "   'It shall be an event of default hereunder by Company if i) Company fails '\n",
            "   'to pay all fees when due and payable pursuant to this Agreement, ii) '\n",
            "   'Company is adjudicated as insolvent or declares bankruptcy, or iii) '\n",
            "   'Company shall materially breach this Agreement and such breach remains '\n",
            "   'uncured for a period of thirty (30) days after written notice thereof from '\n",
            "   'North to Company.'],\n",
            "  ['13.',\n",
            "   'Termination/Remedies. Either party shall have the right to terminate this '\n",
            "   'Agreement upon the occurrence of an event of default by the other party by '\n",
            "   'providing written notice thereof to the defaulting party. All rights and '\n",
            "   'remedies of the parties herein specified are cumulative and are in '\n",
            "   'addition to, not in limitation of, any rights and remedies the parties may '\n",
            "   'have at law or in equity and all such rights and remedies may be exercised '\n",
            "   'singularly or concurrently.'],\n",
            "  ['14.',\n",
            "   'Companys Debts. North shall not be liable for any debts or obligations of '\n",
            "   'Company resulting directly or indirectly from the aforesaid use of the '\n",
            "   'Norths Likeness, Norths Endorsement or the services provided by North. '\n",
            "   'Company shall make no representation, or in any way imply in its actions '\n",
            "   'or failure to act, that North is on will be liablefor debts or obligations '\n",
            "   'of Company.'],\n",
            "  ['15.',\n",
            "   'Indemnification. Company shall indemnify, defend, and hold harmless North '\n",
            "   'and its employees, officers, agents, and representatives from and against '\n",
            "   'any and all claims, suits, assessments, losses, obligations, penalties, '\n",
            "   'charges, actions, damages, liabilities, costs, and expenses including '\n",
            "   'reasonable attorneys fees whether incurred at trial or in connection with '\n",
            "   'any review by appeal or certiorari of both the trial and appellate court '\n",
            "   'levels (collectively referred to as Claims) arising out of or in '\n",
            "   'connection with:'],\n",
            "  ['a',\n",
            "   'Any claim or action for negligent or intentional misconduct of Company in '\n",
            "   'relation to the advertisement, promotion, or sale of the Endorsed Product, '\n",
            "   'or Companys use of Norths Likeness or Norths Endorsement to advertise, '\n",
            "   'promote, distribute, or sell the Endorsed Product; or'],\n",
            "  ['b.',\n",
            "   'Any claim or action for personal injury, death, or property damage '\n",
            "   'resulting from a customers use of the Endorsed Product; or'],\n",
            "  ['c.',\n",
            "   'Any claims or action for the breach by Company of any of its '\n",
            "   'representations and warranties set forth in this Agreement.'],\n",
            "  ['16.',\n",
            "   'Insurance. Company agrees, at its own expense, to obtain and maintain '\n",
            "   'general comprehensive liability insurance, with an insurance company that '\n",
            "   'has a rating of A++ (per AM Best), insuring North as a named insured '\n",
            "   'party, against any claims, suits, losses and damages arising out of or '\n",
            "   'caused by Companys use of Norths Likeness. Norths Endorsement or Norths '\n",
            "   'services hereunder. Such insurance policy shall be maintained with limits '\n",
            "   'of not less than two million dollars ($2,000,000). Said policy of '\n",
            "   'insurance shall remain in force for the duration of this Agreement. A copy '\n",
            "   'of such insurance policy shall be provided to North within thirty (30) '\n",
            "   'days after execution of this Agreement.'],\n",
            "  ['17.',\n",
            "   'Waiver. The failure of either party at any time or times to demand strict '\n",
            "   'performance of the other party of any of the terms, covenants or '\n",
            "   'conditions set forth herein shall not be construed as a continuing waiver '\n",
            "   'or relinquishment thereof and each party may at any time demand strict and '\n",
            "   'complete performance by the other party.'],\n",
            "  ['18.',\n",
            "   'Notices. All notices, claims, certificates, requests, demands and other '\n",
            "   'communication hereunder shall be made in writing and will be deemed to '\n",
            "   'have been duly given if delivered by hand, via facsimile transmission, or '\n",
            "   'mailed and addressed as follows:'],\n",
            "  ['To Company:', 'Golfers Incorporated'],\n",
            "  ['1021 N. Sepulveda Blvd., Suite G'],\n",
            "  ['Manhattan Beach, CA 90266'],\n",
            "  ['Attention: Mike or Steve Abram'],\n",
            "  ['To North:', 'Andy North'],\n",
            "  ['c/o Fidelity Sports Group, LLC'],\n",
            "  ['514 Broadway Avenue'],\n",
            "  ['Orlando, Florida 32803'],\n",
            "  ['Attention: David J. Moorman, President & CEO'],\n",
            "  ['19.',\n",
            "   'Assignment. Neither party to this Agreement shall assign the rights and '\n",
            "   'benefits herein without the prior written consent of the other party.'],\n",
            "  ['20.',\n",
            "   'Independent Contractor. Company has engaged North for certain rights which '\n",
            "   'are set forth in this Agreement, and Norths relationship to Company, and '\n",
            "   'Companys relationship to North, shall at all times be that of an '\n",
            "   'independent contractor.'],\n",
            "  ['21.',\n",
            "   'Joint Venture. This Agreement does not constitute a partnership or joint '\n",
            "   'venture between North and Company. No party shall have the right to '\n",
            "   'obligate or bind the other party in any manner whatsoever.'],\n",
            "  ['22.',\n",
            "   'Governing Law. The Agreement shall be governed by and construed under the '\n",
            "   'laws of the State of Florida in the United States of America, and venue '\n",
            "   'for any such legal action shall be in the Circuit Court or County Court in '\n",
            "   'Orlando, FL or the U.S. District Court having jurisdiction over Orlando, '\n",
            "   'FL.'],\n",
            "  ['23.',\n",
            "   'Entire Agreement. This writing constitutes the entire agreement and '\n",
            "   'understanding between the parties with respect to its subject matter. This '\n",
            "   'Agreement supersedes all prior or contemporaneous agreements and '\n",
            "   'understandings between the parties with respect to its subject matter.'],\n",
            "  ['24.',\n",
            "   'Amendments. This Agreement may be amended only by a written instrument '\n",
            "   'duly executed by both parties.'],\n",
            "  ['25.',\n",
            "   'Authority. Each party warrants and represents to the other that it has the '\n",
            "   'full right, power and authority to enter into and perform this Agreement, '\n",
            "   'to make the covenants and representations contained in this Agreement and '\n",
            "   'further, that the execution, delivery and performance of this Agreement '\n",
            "   'will not violate, conflict with, or constitute a default under, any '\n",
            "   'contract, agreement or undertaking to which it is a party or by which it '\n",
            "   'is bound.'],\n",
            "  ['26.',\n",
            "   'Severability. The illegality, unenforceability or invalidity of any term, '\n",
            "   'clause or provision of this Agreement shall not affect any other term, '\n",
            "   'clause or provision hereof, and this Agreement shall continue in full '\n",
            "   'force and effect, and be construed and enforced, as if such provision had '\n",
            "   'not been included.'],\n",
            "  ['27.',\n",
            "   'Compliance with Laws. Company represents and warrants to North that it '\n",
            "   'will comply with all rules, regulations, laws, orders, decrees and '\n",
            "   'ordinances of the United States, each state and political subdivision '\n",
            "   'thereof, and each and every foreign country having legal jurisdiction over '\n",
            "   'any aspect of Companys activities under this Agreement, including, but not '\n",
            "   'limited to, the use of Norths Likeness in advertisements for and on behalf '\n",
            "   'of the Company.'],\n",
            "  ['28.',\n",
            "   'Attorneys Fees and Costs. The prevailing party in any litigation or other '\n",
            "   'proceeding between the parties arising out of the interpretation, '\n",
            "   'application, or enforcement of any provision of this Agreement shall be '\n",
            "   'entitled to recover all of its reasonable fees, court costs, and expenses, '\n",
            "   'including fees for attorneys, whether incurred at trial or in connection '\n",
            "   'with any review by appeal or certiorari, accountants, and other '\n",
            "   'professionals.'],\n",
            "  ['29.',\n",
            "   'Force Majeure. In the event any of the appearances set forth in this '\n",
            "   'Agreement are cancelled or delayed due to matters of Force Majeure, as '\n",
            "   'such term is defined below, Company and North shall use their reasonable '\n",
            "   'efforts to reschedule such appearance as soon as possible following such '\n",
            "   'cancellation or delay. As used herein, the term Force Majeure shall mean '\n",
            "   'war, civil unrest, acts of God, unusually severe weather, environmental '\n",
            "   'matters, failure of common carrier, governmental action, labor disputes, '\n",
            "   'casualty, illness, injury and/or emergency.'],\n",
            "  ['30.',\n",
            "   'Confidentiality. The compensation terms of this Agreement hereunder and '\n",
            "   'any financial information collected through the review of Companys records '\n",
            "   'or statements shall be treated by the parties as confidential information. '\n",
            "   'The parties hereto agree not to disclose any such terms, amounts or '\n",
            "   'information to any other person or entity whatsoever other than its '\n",
            "   'attorneys, accountants, or as required by law.'],\n",
            "  ['31.',\n",
            "   'Counterparts. This Agreement may be executed in one or more counterparts, '\n",
            "   'each of which shall be deemed an original, but all of which together shall '\n",
            "   'constitute one and the same instrument.'],\n",
            "  ['GOLFERS INCORPORATED:'],\n",
            "  ['/s/ Michael F. Abram', 'WITNESS:', '/s/ [ILLEGIBLE]'],\n",
            "  ['By: Michael F. Abram'],\n",
            "  ['Its: President'],\n",
            "  ['Date: 2-21-11'],\n",
            "  ['/s/ Andy North', 'WITNESS:', '/s/ [ILLEGIBLE]'],\n",
            "  ['Andy North'],\n",
            "  ['Date: 2-20-11']])\n"
          ]
        },
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "('PerformanceSportsBrandsInc_20110909_S-1_EX-10.10_7220214_EX-10.10_Endorsement Agreement.html',\n",
              " {1: ('1. Definitions', {}),\n",
              "  2: ('2. Term', {}),\n",
              "  3: ('3. Grant of License and Exclusivity', {}),\n",
              "  4: ('4. Retention of Rights', {}),\n",
              "  5: ('5. Appearances', {}),\n",
              "  6: ('6. Compensation', {}),\n",
              "  7: ('7. Supply of Endorsed Products', {}),\n",
              "  8: ('8. Approval of Advertising', {}),\n",
              "  9: ('9. Ownership', {}),\n",
              "  10: ('10. SAG and/or AFTRA', {}),\n",
              "  11: ('11. Standards', {}),\n",
              "  12: ('12. Events of Default', {}),\n",
              "  13: ('13. Termination/Remedies', {}),\n",
              "  14: ('14. Companys Debts', {}),\n",
              "  15: ('15. Indemnification', {}),\n",
              "  16: ('16. Insurance', {}),\n",
              "  17: ('17. Waiver', {}),\n",
              "  18: ('18. Notices', {}),\n",
              "  19: ('19. Assignment', {}),\n",
              "  20: ('20. Independent Contractor', {}),\n",
              "  21: ('21. Joint Venture', {}),\n",
              "  22: ('22. Governing Law', {}),\n",
              "  23: ('23 Entire Agreement', {}),\n",
              "  24: ('24. Amendments', {}),\n",
              "  25: ('25. Authority', {}),\n",
              "  26: ('26. Severability', {}),\n",
              "  27: ('27. Compliance with Laws', {}),\n",
              "  28: ('28. Attorneys Fees and Costs', {}),\n",
              "  29: ('29. Force Majeure', {}),\n",
              "  30: ('30. Confidentiality', {}),\n",
              "  31: ('31. Counterparts', {}),\n",
              "  32: ('Orlando, Florida 32803', {})})"
            ]
          },
          "metadata": {},
          "execution_count": 15
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "def extract_labels_to_folder(dict_of_tocs, output_dir):\n",
        "  agg_label_dict = {}\n",
        "  for item in scraping_results.items():\n",
        "    if item[0] in agg_label_dict.keys():\n",
        "      continue\n",
        "    if 'Monsanto Company' in item[0] or 'SoupmanInc' in item[0]:\n",
        "      continue\n",
        "    if not os.path.isdir(output_dir):\n",
        "      os.makedirs(output_dir)\n",
        "    \n",
        "    out = extract_label_to_json(item, output_dir)\n",
        "    agg_label_dict[out[0]] = out[1]\n",
        "    with open('./TOC_Labels_f2', 'w') as f:\n",
        "      json.dump(agg_label_dict, f)\n",
        "\n",
        "extract_labels_to_folder(scraping_results, '/content/drive/My Drive/CDS Capstone Project/out_labels_dir')\n",
        "    "
      ],
      "metadata": {
        "id": "zU2nxqkfuGNc"
      },
      "execution_count": 16,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [
        "# WITH SUBSECTION HIERARCHY IN DICT\n",
        "# SINGLE DICT OUTPUT\n",
        "import re\n",
        "import roman\n",
        "from pprint import pprint\n",
        "\n",
        "\n",
        "agg_label_dict = {}\n",
        "for contract_title, toc in scraping_results.items():\n",
        "  if contract_title in agg_label_dict.keys():\n",
        "    continue\n",
        "  if 'Monsanto Company' in contract_title:\n",
        "    continue\n",
        "    \n",
        "  ## Loop starts here\n",
        "  label_dict = {}\n",
        "  n_section = 1\n",
        "  n_subsection = 1\n",
        "\n",
        "  ### Roman Numeral Check\n",
        "  roman_numerals = ['II', 'III', 'IV', 'VII', 'VIII', 'IX', 'XI', 'XII']\n",
        "  numeral_counter = 0\n",
        "  is_roman = False\n",
        "\n",
        "  for item in toc:\n",
        "    if numeral_counter >= 2:\n",
        "      is_roman = True\n",
        "      break\n",
        "    is_subsection = re.search('\\d\\.(\\d)+', item[0])\n",
        "    if not is_subsection:\n",
        "      if any(romans in item[0] for romans in roman_numerals):\n",
        "        numeral_counter += 1\n",
        "\n",
        "  ### Label Extraction\n",
        "  for item in toc:\n",
        "\n",
        "    # Section number regex rules to handle improperly ordered inputs\n",
        "    if re.search('\\.(\\d\\d) \\n\\d', item[0]):\n",
        "      item[0] = item[0][-2:] + item[0][1:3]\n",
        "    if re.search('\\.(\\d\\d)(\\n)+\\d', item[0]):\n",
        "      item[0] = item[0][-2:] + item[0][1:3]\n",
        "    if re.search('\\.(\\d)+ [\\D]+ \\d\\.', item[0]):\n",
        "      item[0] = item[0][-2:] + item[0][1:-2]\n",
        "    \n",
        "    # Determine if line is a subsection using regex\n",
        "    is_subsection = re.search('(\\d)+\\.(\\d)+', item[0])\n",
        "    # print(item)\n",
        "    if re.search('\\d\\.0', item[0]):\n",
        "      is_subsection = False\n",
        "\n",
        "    if not is_subsection:\n",
        "      n_section_str = roman.toRoman(n_section) if is_roman else f'{n_section}'\n",
        "\n",
        "      if n_section_str in item[0]:\n",
        "        section_title = item[0]\n",
        "\n",
        "        if len(item) > 1:\n",
        "          try:\n",
        "            int(item[1]) \n",
        "          except:\n",
        "            section_title = f'{section_title} {item[1]}'\n",
        "        \n",
        "        label_dict[n_section] = (section_title, {})\n",
        "        n_section += 1\n",
        "        n_subsection = 1\n",
        "\n",
        "    else:\n",
        "      # Is a section title with d.d style numbering\n",
        "      # print(item)\n",
        "      if len(item) == 2:\n",
        "        section_title = ' '.join(re.split('(\\d\\.\\d+)', item[0])).strip() \n",
        "        label_dict[n_section] = (section_title + ' ' + item[1], {})\n",
        "        n_section += 1\n",
        "      # Is an actual subsection\n",
        "      else:\n",
        "        print(n_section, n_subsection, is_subsection.group(), item, contract_title)\n",
        "        label_dict[n_section-1][1][n_subsection] = (f'{is_subsection.group()} {item[1:]}', {})\n",
        "        \n",
        "      n_subsection += 1\n",
        "  agg_label_dict[contract_title] = label_dict\n",
        "  print(label_dict)\n",
        "  print('NEXT DOC')\n",
        "\n"
      ],
      "metadata": {
        "id": "UzuZoJsnzHUC"
      },
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [
        "pprint(agg_label_dict)"
      ],
      "metadata": {
        "id": "2WBa0Ks8QcF_"
      },
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [
        "''' TODO\n",
        "1. ***COMPLETE*** Convert code into a pipeline format(code should take a single html toc and \n",
        "save a json format of labels into a single file. also add a function which \n",
        "iterates over n number of tocs and creates label json outputs in a folder).\n",
        "\n",
        "2. Save this as a python script so it can be imported and either of the \n",
        "functions can be called on the html tocs.\n",
        "\n",
        "3. Output of json key(contract name) should be the everything before the first \n",
        "underscore in the contract title\n",
        "'''"
      ],
      "metadata": {
        "id": "XHjNBzxfaV1H"
      },
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "markdown",
      "source": [
        "Contracts which are have incomplete results or no outputs:\n",
        "\n",
        "VERTEXENERGYINC_08_14_2014-EX-10.24-OPERATION AND MAINTENANCE AGREEMENT.html\n",
        "\n",
        "USASYNTHETICFUELCORP_10_21_2010-EX-10.10-STRATEGIC ALLIANCE AGREEMENT.html\n",
        "\n",
        "SoupmanInc_20150814_8-K_EX-10.1_9230148_EX-10.1_Franchise Agreement1.html\n",
        "\n",
        "PfHospitalityGroupInc_20150923_10-12G_EX-10.1_9266710_EX-10.1_Franchise Agreement1.html\n",
        "\n",
        "HPILHOLDING_01_07_2015-EX-99.1-COOPERATION AGREEMENT.html (has section titles split into words and has superfluous periods as well)\n",
        "\n",
        "CERES,INC_01_25_2012-EX-10.20-Collaboration Agreement.html\n",
        "\n",
        "AzulSa_20170303_F-1A_EX-10.3_9943903_EX-10.3_Maintenance Agreement2.html\n",
        "\n",
        "\n",
        "Lots of articles have this issue of split titles into a list of words. Probably a minor issue to deal with as they can be joined with no risk of joining text from other sections.\n"
      ],
      "metadata": {
        "id": "V81O9Q91JnIa"
      }
    },
    {
      "cell_type": "code",
      "source": [
        "# Convert to output and save as json \n",
        "with open('/content/labelling_results_sample.json', 'w') as f:\n",
        "  json.dump(agg_label_dict, f)"
      ],
      "metadata": {
        "id": "I9PKc_0qIy_a"
      },
      "execution_count": 19,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [
        "# # NO SUBSECTION HIERARCHY\n",
        "# import re\n",
        "# import roman\n",
        "# from pprint import pprint\n",
        "\n",
        "\n",
        "# toc = toc_lists[0]\n",
        "# label_list = []\n",
        "# for toc in toc_lists:\n",
        "#   ## Loop starts here\n",
        "#   label_dict = {}\n",
        "#   n_section = 1\n",
        "\n",
        "#   ### Roman Numeral Check\n",
        "#   roman_numerals = ['II', 'III', 'IV', 'VII', 'VIII', 'IX', 'XI', 'XII']\n",
        "#   numeral_counter = 0\n",
        "#   is_roman = False\n",
        "\n",
        "#   for item in toc:\n",
        "#     if numeral_counter >= 2:\n",
        "#       is_roman = True\n",
        "#       break\n",
        "#     is_subsection = re.search('\\d\\.\\d', item[0])\n",
        "#     if not is_subsection:\n",
        "#       if any(romans in item[0] for romans in roman_numerals):\n",
        "#         numeral_counter += 1\n",
        "\n",
        "#   ### Label Extraction\n",
        "#   for item in toc:\n",
        "#     is_subsection = re.search('\\d\\.\\d', item[0])\n",
        "    \n",
        "#     if not is_subsection:\n",
        "#       n_section_str = roman.toRoman(n_section) if is_roman else f'{n_section}'\n",
        "\n",
        "#       if n_section_str in item[0]:\n",
        "#         section_title = item[0]\n",
        "\n",
        "#         if len(item) > 1:\n",
        "#           try:\n",
        "#             int(item[1]) \n",
        "#           except:\n",
        "#             section_title = f'{section_title} {item[1]}'\n",
        "        \n",
        "#         label_dict[n_section] = (section_title, {})\n",
        "#         n_section += 1\n",
        "\n",
        "#     else:\n",
        "#       label_dict[n_section-1] = (f'{is_subsection.group()} {item[1]}', {})\n",
        "#       n_section += 1\n",
        "#   label_list.append(label_dict)\n",
        "#   break\n",
        "\n"
      ],
      "metadata": {
        "id": "p7qCLHjhM0lC"
      },
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [
        "# pprint(label_list[2])"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "9vzMtQYT20Co",
        "outputId": "ea214a73-ed04-4c5a-8a45-6cf223ecb949"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "{1: ('1. Definitions',\n",
            "     {1: ('1.1 Affiliate', {}),\n",
            "      2: ('1.2 Agreement', {}),\n",
            "      3: ('1.3 Agreement Term', {}),\n",
            "      4: ('1.4 [...***...] ctDNA [...***...]', {}),\n",
            "      5: ('1.5 Applicable Law', {}),\n",
            "      6: ('1.6 Approved Assay', {}),\n",
            "      7: ('1.7 Background IP', {}),\n",
            "      8: ('1.8 Business Day', {}),\n",
            "      9: ('1.9 Calendar Half', {}),\n",
            "      10: ('1.1 Calendar Quarter', {}),\n",
            "      11: ('1.1 Calendar Year', {}),\n",
            "      12: ('1.1 CDx', {}),\n",
            "      13: ('1.1 CDx Development Program', {}),\n",
            "      14: ('1.1 CLIA', {}),\n",
            "      15: ('1.1 Clinical Study', {}),\n",
            "      16: ('1.1 Commercially Reasonable Efforts', {}),\n",
            "      17: ('1.1 Confidential Information', {}),\n",
            "      18: ('1.1 Control', {}),\n",
            "      19: ('1.1 Cover', {}),\n",
            "      20: ('1.2 ctDNA', {}),\n",
            "      21: ('1.2 ctDNA Assay', {}),\n",
            "      22: ('1.2 ctDNA Platform', {}),\n",
            "      23: ('1.2 ctDNA Platform Development Program', {}),\n",
            "      24: ('1.2 ctDNA Working Group', {}),\n",
            "      25: ('1.2 Data Security Breach', {}),\n",
            "      26: ('1.2 Effective Date', {}),\n",
            "      27: ('1.2 Excepted Activities', {}),\n",
            "      28: ('1.2 Excluded Patent Rights', {}),\n",
            "      29: ('1.2 FDA', {}),\n",
            "      30: ('1.3 FDCA', {}),\n",
            "      31: ('1.3 FMI Background IP Patent Rights', {}),\n",
            "      32: ('1.3 FMI Decisions', {}),\n",
            "      33: ('1.3 FMI Development Costs', {}),\n",
            "      34: ('1.3 FMI Know-How', {}),\n",
            "      35: ('1.3 FMI Foreground Patent Rights', {}),\n",
            "      36: ('1.3 FTE', {}),\n",
            "      37: ('1.3 FTE Rate', {}),\n",
            "      38: ('1.3 Handle', {}),\n",
            "      39: ('1.3 HSR', {}),\n",
            "      40: ('1.4 Immunotherapy Testing Platform Development Program', {}),\n",
            "      41: ('1.4 Immuno-Platform Working Group', {}),\n",
            "      42: ('1.4 Initiation', {}),\n",
            "      43: ('1.4 Insolvency Event', {}),\n",
            "      44: ('1.4 Invention', {}),\n",
            "      45: ('1.4 IUO', {}),\n",
            "      46: ('1.4 JMC', {}),\n",
            "      47: ('1.4 JOC', {}),\n",
            "      48: ('1.4 Joint Know-How', {}),\n",
            "      49: ('1.4 Joint Patent Rights', {})})}\n"
          ]
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "# import pickle\n",
        "# with open('/content/drive/My Drive/TOC_Labels_Set2.pkl', 'wb') as f:\n",
        "#   pickle.dump(label_list, f)"
      ],
      "metadata": {
        "id": "ds-rxNjkBAuW"
      },
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [
        "import json\n",
        "with open('/content/scraping_results.json', 'r') as f:\n",
        "  scraping_results = json.load(f)"
      ],
      "metadata": {
        "id": "4LaglhMNtS4U"
      },
      "execution_count": 7,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [
        "from toc_labelling import extract_label_to_json, extract_labels_to_folder"
      ],
      "metadata": {
        "id": "jvC7gIlfok4H"
      },
      "execution_count": 9,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [
        "imp_dict = extract_labels_to_folder(scraping_results, 'labelled_outputs_full')"
      ],
      "metadata": {
        "id": "prMCe-uNAddA"
      },
      "execution_count": 10,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [
        "scraping_results.keys()"
      ],
      "metadata": {
        "id": "x5oWS_OStmjq"
      },
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [
        "scraping_results['XENCORINC_10_25_2013-EX-10.24-COLLABORATION AGREEMENT (3).html']"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "FNQQz9fJt3BS",
        "outputId": "b141dba6-8ffb-483f-ab93-eb7ee36367d0"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "[['1', 'Definitions', '5'],\n",
              " ['1.1', 'Acceptance   Criteria', '5'],\n",
              " ['1.2', 'Affiliated   Companies', '5'],\n",
              " ['1.3', 'Batch', '5'],\n",
              " ['1.4', 'BII   Confidential Information and Know-How', '5'],\n",
              " ['1.5', 'BII   Facility', '6'],\n",
              " ['1.6', 'BII   Intellectual Property', '6'],\n",
              " ['1.7', 'BII   Technology', '6'],\n",
              " ['1.8', 'Business   Partner', '6'],\n",
              " ['1.9', 'Certificate   of Analysis', '6'],\n",
              " ['1.10', 'Claim', '6'],\n",
              " ['1.11', 'CMO', '6'],\n",
              " ['1.12', 'Confidential   Information-and Know-How', '6'],\n",
              " ['1.13', 'Confirmation   of Compliance', '6'],\n",
              " ['1.14', 'Controlled   Technology', '6'],\n",
              " ['1.15', 'cGMP', '6'],\n",
              " ['1.16', 'Deliverables', '7'],\n",
              " ['1.17', 'Due   Date', '7'],\n",
              " ['1.18', 'Effective   Date', '7'],\n",
              " ['1.19', 'FTE', '7'],\n",
              " ['1.20', 'Improvements', '7'],\n",
              " ['1.21', 'Knowledge', '7'],\n",
              " ['1.22', 'Latent   Defects', '7'],\n",
              " ['1.23', 'Licensing   Revenue', '7'],\n",
              " ['1.24', 'Losses', '7'],\n",
              " ['1.25', 'Major   Territories', '7'],\n",
              " ['1.26', 'Material', '7'],\n",
              " ['1.27', 'MTA', '7'],\n",
              " ['1.28', 'Obvious   Defects', '8'],\n",
              " ['1.29', 'Other   Improvements', '8'],\n",
              " ['1.30', 'Principal   Supplier', '8'],\n",
              " ['1.31', 'Process', '8'],\n",
              " ['1.32', 'Process   Description', '8'],\n",
              " ['1.33', 'Product', '8'],\n",
              " ['1.34', 'Project', '8'],\n",
              " ['1.35', 'Project   Fees', '8'],\n",
              " ['1.36', 'Project   Manager', '8'],\n",
              " ['1.37', 'Project   Plan', '8'],\n",
              " ['1.38', 'Project   Team', '8'],\n",
              " ['1.39', 'QAA', '9'],\n",
              " ['1.40', 'Representatives', '9'],\n",
              " ['1.41', 'Service(s)', '9'],\n",
              " ['1.42', 'Specification(s)', '9'],\n",
              " ['1.43', 'Steering   Committee', '9'],\n",
              " ['1.44', 'Technology', '9'],\n",
              " ['1.45', 'Technology   Access Fee', '9'],\n",
              " ['1.46', 'Total   Amount', '9'],\n",
              " ['1.47', 'XENCOR   Confidential Information and Know-How', '9'],\n",
              " ['1.48', 'XENCOR   Intellectual Property', '9'],\n",
              " ['1.49', 'XENCOR   Technology', '9'],\n",
              " ['2', 'Cooperation   between the Parties in the Course of a Project', '10'],\n",
              " ['2.1', 'General', '10'],\n",
              " ['2.1.1', 'General', '10'],\n",
              " ['2.1.2', 'Priority', '10'],\n",
              " ['2.2', 'Personnel', '10'],\n",
              " ['2.2.1', 'Designation   of Project Manager', '10'],\n",
              " ['2.2.2', 'Project   Team', '10'],\n",
              " ['2.2.3', 'Steering   Committee', '11'],\n",
              " ['2.3', 'Conduct   of the Project and BIIs Work and Tasks', '11'],\n",
              " ['2.4', 'Deliverables', '12'],\n",
              " ['2.5', 'Nature   of the Project', '12'],\n",
              " ['2.6', 'Additional   Work', '12'],\n",
              " ['2.7', 'XENCOR   Confidential Information and Know-How and Material', '12'],\n",
              " ['2.8', 'Further   Obligations of XENCOR', '13'],\n",
              " ['2.8.1', 'General', '13'],\n",
              " ['2.8.2', 'Obligations   of XENCOR', '13'],\n",
              " ['2.8.3', 'Timelines   and Information', '13'],\n",
              " ['3', 'Payments', '14'],\n",
              " ['3.1', 'Project   Fee', '14'],\n",
              " ['3.1.1', 'Consideration   for Services', '14'],\n",
              " ['3.1.2', 'Payment   of the Project Fees', '14'],\n",
              " ['3.1.3', 'Invoicing', '15'],\n",
              " ['3.2', 'Technology   Access Fee', '15'],\n",
              " ['3.3', 'VAT', '15'],\n",
              " ['4', 'Delivery   Terms of Product', '16'],\n",
              " ['4.1', 'Delivery   Terms', '16'],\n",
              " ['4.2', 'Cancellation   of Order', '17'],\n",
              " ['5', 'Ownership   and Use of Project Data', '17'],\n",
              " ['5.1', 'Project   Data', '17'],\n",
              " ['5.2', 'Use   of the Process; Right of Negotiation', '18'],\n",
              " ['5.2.1', 'Use   of the Process outside this Agreement', '18'],\n",
              " ['5.2.2', 'Right   of First Negotiation to Manufacture', '18'],\n",
              " ['5.2.3', 'Technology   Access Fee and Technology Transfer', '20'],\n",
              " ['5.2.4', 'Payment   Terms', '21'],\n",
              " ['5.2.5', 'License', '21'],\n",
              " ['5.3', 'Acknowledgement', '21'],\n",
              " ['6', 'Representations,   Warranties and Indemnification', '22'],\n",
              " ['6.1', 'Mutual   Representations, Warranties and Covenants', '22'],\n",
              " ['6.2', 'XENCOR   Warranties', '22'],\n",
              " ['6.3', 'BII   Warranties', '22'],\n",
              " ['6.4',\n",
              "  'Process   for Defense of Infringement of Third Party Intellectual Property',\n",
              "  '23'],\n",
              " ['6.5', 'Disclaimer   of Warranties', '24'],\n",
              " ['7', 'Liability,Indemnification,   Limitations and Insurance', '24'],\n",
              " ['7.1', 'General', '24'],\n",
              " ['7.2', 'Liability', '24'],\n",
              " ['7.3', 'Indemnification', '25'],\n",
              " ['7.4', 'Limitation   of Liability and Indemnification Obligations', '25'],\n",
              " ['7.5', 'Insurance', '26'],\n",
              " ['8', 'Intellectual   Property', '26'],\n",
              " ['8.1', 'Existing   Intellectual Property Rights', '26'],\n",
              " ['8.2', 'New   Intellectual Property, Project Results and Licenses', '26'],\n",
              " ['8.2.1', 'XENCOR', '26'],\n",
              " ['8.2.2', 'BII', '27'],\n",
              " ['8.2.3', 'Other   Improvements', '27'],\n",
              " ['8.2.4', 'Licenses   to Xencor', '27'],\n",
              " ['8.2.5', 'Licenses   to BII', '27'],\n",
              " ['9', 'Confidentiality', '28'],\n",
              " ['9.1', 'General', '28'],\n",
              " ['9.2', 'MTA   Superseded', '30'],\n",
              " ['9.3', 'Controlled   Technology', '30'],\n",
              " ['10', 'Term   and Termination', '30'],\n",
              " ['10.1', 'Term', '30'],\n",
              " ['10.2', 'Termination   of this Agreement', '30'],\n",
              " ['10.2.1', '30'],\n",
              " ['10.2.2', '30'],\n",
              " ['10.3', 'Effects   of Termination of this Agreement', '31'],\n",
              " ['10.3.2', '31'],\n",
              " ['10.3.3', '32'],\n",
              " ['10.4', 'Surviving   Provisions', '32'],\n",
              " ['11', 'Miscellaneous', '32'],\n",
              " ['11.1', 'Force   Majeure', '32'],\n",
              " ['11.2', 'Conflict   with Improvements under the MTA', '33'],\n",
              " ['11.3', 'Secrecy   Agreement between the Parties', '33'],\n",
              " ['11.4', 'Publicity', '33'],\n",
              " ['11.5', 'Notices', '33'],\n",
              " ['11.6', 'Applicable   Law and Arbitration', '34'],\n",
              " ['11.7', 'Entire   Agreement', '34'],\n",
              " ['11.8', 'Waiver;   Amendment', '34'],\n",
              " ['11.9', 'Severability', '35'],\n",
              " ['11.10', 'Dispute Resolution', '35'],\n",
              " ['11.11', 'Assignment', '35'],\n",
              " ['11.12', 'Independent Contractors', '35'],\n",
              " ['11.13', 'Counterparts', '35'],\n",
              " ['Account   Name:', '[...***...]'],\n",
              " ['Account   Number:', '[...***...]'],\n",
              " ['Bank:', '[...***...]'],\n",
              " ['BIC (SWIFT-CODE):', '[...***...]'],\n",
              " ['IBAN:', '[...***...]']]"
            ]
          },
          "metadata": {},
          "execution_count": 16
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [],
      "metadata": {
        "id": "qmFmsVZ_gtSC"
      },
      "execution_count": null,
      "outputs": []
    }
  ]
}